Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 4-(6-bromoveratryl)-4-(2-(2-(6,6-dimethyl-2-norpinyl)ethoxy)ethyl)morpholinium Bromide
2. Dicetel
3. Eldicet
4. Pinaverium
1. 53251-94-8
2. Dicetel
3. Pinaverium Bromide [inn]
4. Lat-1717
5. Pinaverium Bromide (inn)
6. Morpholinium, 4-[(2-bromo-4,5-dimethoxyphenyl)methyl]-4-[2-[2-(6,6-dimethylbicyclo[3.1.1]hept-2-yl)ethoxy]ethyl]-, Bromide (1:1)
7. Pinaverii Bromidum
8. 4-(2-bromo-4,5-dimethoxybenzyl)-4-(2-(2-(6,6-dimethylbicyclo[3.1.1]heptan-2-yl)ethoxy)ethyl)morpholin-4-ium Bromide
9. Bromuro De Pinaverio
10. Bromure De Pinaverium
11. Lat 1717
12. Pinaverii Bromidum [inn-latin]
13. Bromure De Pinaverium [inn-french]
14. Bromuro De Pinaverio [inn-spanish]
15. 4-[(2-bromo-4,5-dimethoxyphenyl)methyl]-4-[2-[2-(6,6-dimethyl-2-bicyclo[3.1.1]heptanyl)ethoxy]ethyl]morpholin-4-ium;bromide
16. 4-(6-bromoveratryl)-4-(2-(2-(6,6-dimethyl-2-norpinyl)ethoxy)ethyl)morpholinium Bromide
17. Ncgc00181763-01
18. Einecs 258-450-0
19. 7scf54h12j
20. Unii-7scf54h12j
21. Pinaveriumbromide-d4
22. Dsstox_cid_28540
23. Dsstox_rid_82812
24. Dsstox_gsid_48614
25. Schembl25474
26. Morpholinium, 4-(2-bromo-4,5-dimethoxy)benzyl-4-(2-(2-(6,6-dimethyl-2-norpinyl)ethoxy)ethyl)-, Bromide
27. Chembl1909298
28. Dtxsid2048614
29. 4-[(2-bromo-4,5-dimethoxy-phenyl)methyl]-4-[2-[2-[(1s,5s)-6,6-dimethylnorpinan-2-yl]ethoxy]ethyl]morpholin-4-ium Bromide
30. Bcp21168
31. Tox21_112949
32. Mfcd01713435
33. Akos015918115
34. Gs-6842
35. 4-[(2-bromo-4,5-dimethoxyphenyl)methyl]-4-[2-[2-(6,6-dimethylbicyclo[3.1.1]-hept-2-yl)ethoxy]ethyl]morpholinium Bromide
36. Cas-53251-94-8
37. Hy-111613
38. Cs-0088569
39. Ft-0673906
40. P2753
41. D07094
42. Lat 1717; Lat-1717; Lat1717
43. A870784
44. Q27268790
45. 4-(2-bromo-4,5-dimethoxybenzyl)-4-{2-[2-(6,6-dimethylbicyclo[3.1.1]hept-2-yl)ethoxy]ethyl}morpholin-4-ium Bromide
46. 4-[(2-bromo-4,5-dimethoxy-phenyl)methyl]-4-[2-[2-(6,6-dimethylnorpinan-2-yl)ethoxy]ethyl]-1-oxa-4-azoniacyclohexane Bromide
47. 4-[(2-bromo-4,5-dimethoxyphenyl)methyl]-4-[2-(2-{6,6-dimethylbicyclo[3.1.1]heptan-2-yl}ethoxy)ethyl]morpholin-4-ium Bromide
48. Morpholinium,4-[(2-bromo-4,5-dimethoxyphenyl)methyl]-4-[2-[2-(6,6-dimethylbicyclo[3.1.1]hept-2-yl)ethoxy]ethyl]-, Bromide
| Molecular Weight | 591.4 g/mol |
|---|---|
| Molecular Formula | C26H41Br2NO4 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 10 |
| Exact Mass | 591.13818 g/mol |
| Monoisotopic Mass | 589.14023 g/mol |
| Topological Polar Surface Area | 36.9 Ų |
| Heavy Atom Count | 33 |
| Formal Charge | 0 |
| Complexity | 596 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 3 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Calcium Channel Blockers
A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)
Parasympatholytics
Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Global Sales Information
Market Place
ABOUT THIS PAGE
40
PharmaCompass offers a list of Pinaverium Bromide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Pinaverium Bromide manufacturer or Pinaverium Bromide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Pinaverium Bromide manufacturer or Pinaverium Bromide supplier.
PharmaCompass also assists you with knowing the Pinaverium Bromide API Price utilized in the formulation of products. Pinaverium Bromide API Price is not always fixed or binding as the Pinaverium Bromide Price is obtained through a variety of data sources. The Pinaverium Bromide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Pinaverii bromidum [INN-Latin] manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Pinaverii bromidum [INN-Latin], including repackagers and relabelers. The FDA regulates Pinaverii bromidum [INN-Latin] manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Pinaverii bromidum [INN-Latin] API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Pinaverii bromidum [INN-Latin] manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Pinaverii bromidum [INN-Latin] supplier is an individual or a company that provides Pinaverii bromidum [INN-Latin] active pharmaceutical ingredient (API) or Pinaverii bromidum [INN-Latin] finished formulations upon request. The Pinaverii bromidum [INN-Latin] suppliers may include Pinaverii bromidum [INN-Latin] API manufacturers, exporters, distributors and traders.
click here to find a list of Pinaverii bromidum [INN-Latin] suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Pinaverii bromidum [INN-Latin] DMF (Drug Master File) is a document detailing the whole manufacturing process of Pinaverii bromidum [INN-Latin] active pharmaceutical ingredient (API) in detail. Different forms of Pinaverii bromidum [INN-Latin] DMFs exist exist since differing nations have different regulations, such as Pinaverii bromidum [INN-Latin] USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Pinaverii bromidum [INN-Latin] DMF submitted to regulatory agencies in the US is known as a USDMF. Pinaverii bromidum [INN-Latin] USDMF includes data on Pinaverii bromidum [INN-Latin]'s chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Pinaverii bromidum [INN-Latin] USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Pinaverii bromidum [INN-Latin] suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Pinaverii bromidum [INN-Latin] Drug Master File in Korea (Pinaverii bromidum [INN-Latin] KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Pinaverii bromidum [INN-Latin]. The MFDS reviews the Pinaverii bromidum [INN-Latin] KDMF as part of the drug registration process and uses the information provided in the Pinaverii bromidum [INN-Latin] KDMF to evaluate the safety and efficacy of the drug.
After submitting a Pinaverii bromidum [INN-Latin] KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Pinaverii bromidum [INN-Latin] API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Pinaverii bromidum [INN-Latin] suppliers with KDMF on PharmaCompass.
A Pinaverii bromidum [INN-Latin] written confirmation (Pinaverii bromidum [INN-Latin] WC) is an official document issued by a regulatory agency to a Pinaverii bromidum [INN-Latin] manufacturer, verifying that the manufacturing facility of a Pinaverii bromidum [INN-Latin] active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Pinaverii bromidum [INN-Latin] APIs or Pinaverii bromidum [INN-Latin] finished pharmaceutical products to another nation, regulatory agencies frequently require a Pinaverii bromidum [INN-Latin] WC (written confirmation) as part of the regulatory process.
click here to find a list of Pinaverii bromidum [INN-Latin] suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Pinaverii bromidum [INN-Latin] as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Pinaverii bromidum [INN-Latin] API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Pinaverii bromidum [INN-Latin] as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Pinaverii bromidum [INN-Latin] and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Pinaverii bromidum [INN-Latin] NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Pinaverii bromidum [INN-Latin] suppliers with NDC on PharmaCompass.
Pinaverii bromidum [INN-Latin] Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Pinaverii bromidum [INN-Latin] GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Pinaverii bromidum [INN-Latin] GMP manufacturer or Pinaverii bromidum [INN-Latin] GMP API supplier for your needs.
A Pinaverii bromidum [INN-Latin] CoA (Certificate of Analysis) is a formal document that attests to Pinaverii bromidum [INN-Latin]'s compliance with Pinaverii bromidum [INN-Latin] specifications and serves as a tool for batch-level quality control.
Pinaverii bromidum [INN-Latin] CoA mostly includes findings from lab analyses of a specific batch. For each Pinaverii bromidum [INN-Latin] CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Pinaverii bromidum [INN-Latin] may be tested according to a variety of international standards, such as European Pharmacopoeia (Pinaverii bromidum [INN-Latin] EP), Pinaverii bromidum [INN-Latin] JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Pinaverii bromidum [INN-Latin] USP).
